PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2022-02-16

Date Title Company
16-Feb-2022 Relief Reports that its U.S. Collaboration Partner has Announced that the U.S. National Institutes of Health Study of Aviptadil in Critical COVID-19 is Cleared to Complete Full Enrollment Relief Therapeutics Holding SA